Anika Therapeutics, Inc. (ANIK) Profit Breakdown
- 2026-06-30: Single Reportable $21.24M.
- 2025-06-30: Single Reportable $14.36M.
Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.
- Available history
- 2009-12-31 to 2026-06-30
- Data captured
Profit by product
Gross profit: each quarter (3 month)
| Quarter end | Single Reportable |
|---|
| 2026-06-30 | $21.24M |
|---|
| 2025-06-30 | $14.36M |
|---|
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest: each quarter (3 month)
| Quarter end | Single Reportable |
|---|
| 2026-06-30 | $3.38M |
|---|
| 2025-06-30 | -$3.97M |
|---|
Net Income (Loss) Attributable to Parent: each quarter (3 month)
| Quarter end | Single Reportable |
|---|
| 2026-06-30 | $3.31M |
|---|
| 2025-06-30 | -$3.97M |
|---|
Operating income: each quarter (3 month)
| Quarter end | Single Reportable |
|---|
| 2026-06-30 | $2.95M |
|---|
| 2025-06-30 | -$4.18M |
|---|